A detailed history of Fmr LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Fmr LLC holds 1,342 shares of CELC stock, worth $21,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,342
Previous 1,336 0.45%
Holding current value
$21,270
Previous $28,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $84 - $124
6 Added 0.45%
1,342 $21,000
Q1 2024

May 13, 2024

BUY
$13.74 - $21.6 $1,044 - $1,641
76 Added 6.03%
1,336 $28,000
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $7,377 - $12,736
848 Added 205.83%
1,260 $18,000
Q3 2023

Nov 13, 2023

BUY
$8.96 - $10.75 $3,028 - $3,633
338 Added 456.76%
412 $3,000
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $694 - $901
74 New
74 $0
Q2 2022

Aug 12, 2022

BUY
$5.35 - $10.11 $674 - $1,273
126 New
126 $1,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $237M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.